SEC ownership of Novo Integrated Sciences, Inc.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001138978.

Comparable stake leader

Robert Letterio Oliva

Disclosed value leader

Robert Letterio Oliva

Comparable rows

0/5

Latest evidence

16 Jan 2024

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 1 signal
Latest parsed ownership date
16 Jan 2024
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001138978
Issuer location
Bellevue, WA

Ownership snapshot

Top shareholders of Novo Integrated Sciences, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Robert Letterio Oliva
Disclosed value leader
Robert Letterio Oliva
Comparable rows
0/5
Latest evidence
16 Jan 2024
3/4/5 Highest disclosed value: $489,863 5 rows are not safely comparable across share classes.

Quick read

Robert Letterio Oliva has the largest disclosed position value at $489.9K.

0 of 5 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Robert Letterio Oliva's linked filing trail.
Disclosed position value Top 1
Robert Letterio Oliva $489.9K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-5 of 5 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Robert Letterio Oliva
3/4/5
Director
class O/S missing
$489,863
217,717 shares
19 Apr 2022
Christopher Mehlin David
3/4/5
Chief Operating Officer, Director
mixed-class rows
208,195 shares
mixed-class rows
16 Jan 2024
Alex Flesias
3/4/5
Director
class O/S missing
93,995 shares
23 Feb 2022
Pope Michael Ross
3/4/5
Director
class O/S missing
93,995 shares
23 Feb 2022
Sarfaraz Ali
3/4/5
Director
class O/S missing
39,480 shares
09 Aug 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 04 Aug 2025.

Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-5 of 5 reporting-owner rows connected to Novo Integrated Sciences, Inc.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
5
Largest Forms 3/4/5 holder
Robert Letterio Oliva
Net 12M change
$0
Latest report
16 Jan 2024
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Robert Letterio Oliva Director $489,863 Filing P/S 19 Apr 2022
Alex Flesias Director Mixed 23 Feb 2022
Pope Michael Ross Director Mixed 23 Feb 2022
Christopher Mehlin David Chief Operating Officer, Director Mixed 16 Jan 2024
Sarfaraz Ali Director Mixed 09 Aug 2022

Recent insider transactions for Novo Integrated Sciences, Inc.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .